SI
Scynexis Inc
🇺🇸XNAS.SCYXUnited StatesHealthcare
$4.14USDdown -0.24 (-5.48%)ClosedDelayed12:49 PM
Price$4.14-0.24 (-5.48%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US8112923094
- CUSIP
- 811292101
Company
- Employees
- 18
- Headquarters
- Jersey City, United States
- Website
- https://www.scynexis.com
- CEO
- Dr. David Gonzalez Angulo M.D.
Market
- Shares outstanding
- 9.9M
- Market cap
- $41.19M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $41.19M
- EPS LTM
- -$0.87
- P/E LTM
- -4.57
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $19.22M+489.78%up year on year
- Net income
- -$10.24M+47.56%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$13.31M+44.78%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.